Mature Results from EORTC 22033: Implications of Inferior Results with Monotherapy for Grade 2 Gliomas

Neuro Oncol. 2026 Jul 20:noag162. doi: 10.1093/neuonc/noag162. Online ahead of print.

¹ Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Division of Neuro-Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA.

No abstract available